Skip to main content

Closed

AVIR: Atea Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-78.1%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio7.89×

Atea Pharmaceuticals, Inc.

AVIRNASDAQ·USD·Closed

Atea Pharmaceuticals, Inc.

AVIRNASDAQ·USD·Closed

$4.70

−0.84%

$4.70

−$0.04 (0.84%)

52W Range

52thpctl

Volume

1.30×avg

Mkt Cap

376.13MUSD

P/E

-2.2TTM

Div Yield

–ann

52W Range

52thpctl

Volume

1.30×avg

Market Cap

376.13MUSD

P/E Ratio

-2.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings